NO981282L - Calcitriolderivater og deres anvendelser - Google Patents

Calcitriolderivater og deres anvendelser

Info

Publication number
NO981282L
NO981282L NO981282A NO981282A NO981282L NO 981282 L NO981282 L NO 981282L NO 981282 A NO981282 A NO 981282A NO 981282 A NO981282 A NO 981282A NO 981282 L NO981282 L NO 981282L
Authority
NO
Norway
Prior art keywords
compounds
vitamin
modified
calcitriol
modified compound
Prior art date
Application number
NO981282A
Other languages
English (en)
Other versions
NO981282D0 (no
Inventor
Hector F Deluca
Heinrich K Schnoes
Zu Yun Cai
Mary E Phelps
Connie M Smith
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/531,403 external-priority patent/US5952317A/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO981282D0 publication Critical patent/NO981282D0/no
Publication of NO981282L publication Critical patent/NO981282L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Abstract

En fremgangsmåte for å behandle metaboliske sykdommer slik som osteoporose, samt andre sykdomstilstander som kan behandles med vitamin D- forbindelser, omfatter å administrere en effektiv mengde av en eller flere modifiserte vitamin D- forbindelser. Den modifiserte forbindelsen inneholder en typisk vitamin D-kjerne, men med in vivo hydrolyserbare grupper på en eller flere posisjoner l, 3 og 25 karbonene. Tiden for kon- versjon av den modifiserte forbindelsen til sin aktive form, slik som calcitriol, kan bli regulert for dermed å fremskaffe kontollert frigivelse av forbindelser in vivo over tid, ved å endre eller modifisere de hydrolyserbare gruppene.
NO981282A 1995-09-21 1998-03-20 Calcitriolderivater og deres anvendelser NO981282L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53186795A 1995-09-21 1995-09-21
US08/531,403 US5952317A (en) 1995-09-21 1995-09-21 Calcitriol derivatives and their uses
PCT/US1996/015184 WO1997011053A1 (en) 1995-09-21 1996-09-20 Calcitriol derivatives and their uses

Publications (2)

Publication Number Publication Date
NO981282D0 NO981282D0 (no) 1998-03-20
NO981282L true NO981282L (no) 1998-05-22

Family

ID=27063537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981282A NO981282L (no) 1995-09-21 1998-03-20 Calcitriolderivater og deres anvendelser

Country Status (9)

Country Link
EP (1) EP1021401A1 (no)
JP (1) JP3372259B2 (no)
KR (1) KR100327922B1 (no)
AU (1) AU717238B2 (no)
CA (1) CA2229316C (no)
HU (1) HUP9802303A3 (no)
NO (1) NO981282L (no)
NZ (2) NZ501318A (no)
WO (1) WO1997011053A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5305600A (en) * 1999-08-17 2001-03-13 Wisconsin Alumni Research Foundation Animal feed containing hydrolyzable calcitriol derivatives
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
US20020045606A1 (en) 1999-12-02 2002-04-18 Reddy Satyanarayana G. Esters of vitamin D3 and uses thereof
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
JP2007525533A (ja) 2004-03-01 2007-09-06 ビオエクセル エスピーエー 間質性膀胱炎の治療方法、並びに関連化合物及び組成物
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treatment of Vitamin D Insufficiency and Deficiency with 25-Hydroxy-D2 and 25-Hydroxy-D3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
EP3542792B1 (en) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Controlled release 25-hydroxyvitamin d
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
KR101852042B1 (ko) 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN114681468A (zh) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 利用25-羟基维生素d的辅助疗法
TW202214257A (zh) 2016-03-28 2022-04-16 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素d治療之方法
KR101983654B1 (ko) * 2018-07-24 2019-05-29 한국과학기술원 Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물
CN114656413B (zh) * 2022-03-30 2024-04-09 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物及其制备方法
CN114681467B (zh) * 2022-03-30 2024-03-12 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物在制备抗肿瘤药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4206131A (en) * 1978-06-19 1980-06-03 The Upjohn Company Compounds and process
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS5846508A (ja) * 1981-09-14 1983-03-18 日本石油化学株式会社 導電性材料の製法
FR2530624B1 (fr) * 1982-07-26 1987-08-07 Wisconsin Alumni Res Found Nouveaux analogues de la vitamine d et compositions pharmaceutiques ou veterinaires les contenant
JPH0825993B2 (ja) * 1990-08-20 1996-03-13 大同ほくさん株式会社 ビタミンｄ２およびｄ３又は活性型ビタミンｄ２およびｄ３の製造方法，並びにその中間体
JPH05339230A (ja) * 1992-03-12 1993-12-21 Nisshin Flour Milling Co Ltd 活性型ビタミンｄ２及びその誘導体の製造法
JP3182215B2 (ja) * 1992-06-26 2001-07-03 日清製粉株式会社 １−アシルオキシビタミンｄ誘導体

Also Published As

Publication number Publication date
CA2229316A1 (en) 1997-03-27
HUP9802303A2 (hu) 1999-02-01
AU717238B2 (en) 2000-03-23
JPH11511475A (ja) 1999-10-05
EP1021401A1 (en) 2000-07-26
MX9801943A (es) 1998-08-30
NZ319819A (en) 2000-02-28
KR19990063628A (ko) 1999-07-26
CA2229316C (en) 2005-04-12
AU7242696A (en) 1997-04-09
NZ501318A (en) 2001-07-27
KR100327922B1 (ko) 2002-05-09
NO981282D0 (no) 1998-03-20
HUP9802303A3 (en) 1999-05-28
JP3372259B2 (ja) 2003-01-27
WO1997011053A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
NO981282L (no) Calcitriolderivater og deres anvendelser
NO20050204L (no) Kombinasjoner av legemidler for behandling av neoplasmer
CO5160365A1 (es) Celulosa microfibrilar estabilizada
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BR9608547A (pt) Método para melhorar a sa·de animal
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
DE60018881D1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
BRPI0408256A (pt) composto, métodos de tratamento de um humano ou animal, pela limitação da replicação de células, que sofre de cáncer, que sofre de uma doença neoplástica, e que se sofre de doenças proliferativas, uso de um composto, e, processo para a preparação de um composto ou de um seu sal farmaceuticamente aceitável ou de um éster hidrolisável in vivo do mesmo
NO174764B (no) Fremgangsmåte for fremstilling av et preparat som er virksomt ved behandling av hyperkeratotiske og andre hudsykdommer
IE821797L (en) 26,26,26,27,27,27-hexafluoro-1ó,25-dihydroxy-cholecalciferol¹derivatives
DK0665749T3 (da) Sammensætning til behandling af Parkinsons sygdom
AU6143794A (en) Use of riluzole for treating aids-related neural disorders
ATE229809T1 (de) Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
ATE448788T1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
AU5056096A (en) External therapeutic composition for dermatitis
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
Hunskaar A case of ecthyma contagiosum (human orf) treated with idoxuridine
SE8107468L (sv) Komposition for behandling av psoriasis pa basis av en 1,8-dihydroxi-9-antron substituerad i 10-stellningen
BR9709989A (pt) Processos para tratamento de uma doenca de planta, para preparacão de uma substância ou composicão para tratamento de doenca de planta e para fertilizacão de uma planta, para fertilizacao de uma planta, substâncias ou composicões para tratamento de uma doenca de planta e para fertilizacão de uma planta, e, uso das mesmas.
ES2093226T3 (es) Retinoides sustituidos con un ciclo ditiano y su empleo, procedimiento de preparacion de dichos compuestos, composiciones cosmetica y farmaceutica que los contienen y empleo terapeutico de esta ultima.
JPS5241447A (en) Sludge treating method
JPS5239960A (en) Method for treating stency sewage
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application